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Abstract 
 
Problem: Heart failure is a chronic, progressive disease with a high symptom burden and 
mortality rate. Many patients in this population do not understand the disease trajectory, nor do 
many cardiologists have advance care planning (ACP) conversations with their patients. This 
combination increases the probability that patients and families will experience aggressive care 
with unnecessary pain at the end of their lives. ACP conversations can decrease the distress of 
both families and patients with chronic diseases; however, only 5-15% of physicians have these 
discussions with their patients. There are various tools available in the literature to assist 
providers in engaging in ACP conversations, but there is a lack of protocol that addresses 
comprehensive aspects of ACP conversations at outpatient heart failure clinics. 
Project Aim: The aim of this quality improvement project was to chronicle the development and 
evaluation of an evidenced-based protocol to improve ACP processes in a heart failure clinic. 
This comprehensive protocol incorporated various tools and resources regarding ACP. 
Project Method: This quality improvement project was conducted using a literature search, 
gathering, analyzing and synthesizing the data and producing a protocol for ACP in an outpatient 
heart failure clinic. The protocol was reviewed and evaluated by cardiology experts in the field 
using the modified AGREE II tool.  
Results: Two cardiology providers with expertise in heart failure reviewed the protocol and 
responded with quantitative data from the modified AGREE II tool and qualitative data including 
implementation feasibility, protocol usefulness, and suggested protocol improvements. There 
were five domains in the modified AGREE II tool, with a score of > 70% required to be 
considered high quality. Domain scores ranged from 79%-92%. Both experts stated the protocol 
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would be useful but did identify barriers including administrative barriers, length of appointment 
times, and need for additional staff.    
Conclusion: A protocol for increasing ACP conversations in an outpatient heart failure clinic is 
feasible and would be useful to both patients and staff, however known barriers would need to be 
overcome to facilitate implementation.  
 Keywords: Advance Care Planning, Heart Failure, Protocol, Advance Directives, 
Advance Care Planning Conversations, Outpatient Clinic 
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Creating a Protocol to Increase Advance Care Planning Conversations 
with Heart Failure Patients in an Outpatient Clinic 
Heart failure is a chronic condition that occurs when the heart muscle is weakened and 
fails to pump blood effectively throughout the body, leading to difficulty breathing, fatigue and 
extremity swelling (Centers for Disease Control and Prevention [CDC], 2016).  It is a 
progressive disease that rivals cancer in terms of symptom burden (Lewin & Shaefer, 2017). It 
affects almost 5.7 million Americans, costs $30.7 billion per year, and has a mortality rate of 
50% within 5 years of diagnosis (Ba, Gelfman, Horton & Goldstein, 2017; Lewin & Schaefer, 
2017). Heart failure is projected to increase 46% by 2030 and will affect greater than 8 million 
people (Benjamin et al., 2017). 
As the symptoms of heart failure progress, so does the chance of a medical emergency 
that may make it difficult for an individual to make his or her own medical decisions, possibly 
leading to an unnecessarily prolonged and painful death (CDC, 2017a). Fortunately, a person 
may complete an advance directive (AD) and state in writing his or her preferences for care and 
appoint a durable power of attorney for healthcare (DPOAHC) to make medical decisions when 
that person does not have decision-making capacity; however, only 30% of Americans have 
completed this document (CDC, 2017a). Exploring the wishes of an older adult with chronic 
disease through an advance care planning (ACP) conversation elicits future patient wishes and 
preferences and may decrease future suffering for both patients and their caregivers (Sullivan & 
Dickerson, 2016). Advance care planning is the process of discussing a patient’s medical wishes 
for serious illness or end-of-life care with the patient and family members and recording these 
wishes in ADs. This should be a recurring process and not a one-time discussion.  
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Statement of Problem 
 Advance care planning conversations and the presence of ADs are important as they 
increase the chances that a person’s wishes about care with serious illness or at the end-of-life 
will be known and respected. ACP can include completing an AD such as a living will and/or 
DPOAHC. It also may include the completion of a Physician Order for Life Sustaining 
Treatment (POLST) or a Transportable Physician Order for Patient Preferences (TPOPP) form 
with medical orders reflecting a patient’s preferences for care during an emergency or at end-of-
life.  Although most adults believe ACP conversations are important before they are seriously ill 
only 5-15% of physicians have this discussion with their patients (Sullivan & Dickerson, 2016). 
It is not the intention of any healthcare provider to cause a patient or family harm but avoiding 
ACP conversations indirectly causes harm (Bernacki & Block, 2014; Klindtworth et al., 2015).  
Advance care planning is associated with an improved quality of life (Meyers & Goodlin, 2016). 
The timely initiation of an ACP conversation increases the likelihood that a patient’s wishes are 
known and documented with the hope that needless suffering can be averted (Chandar et al., 
2017; Sullivan & Dickerson, 2016).  
 Heart failure is a terminal illness with a mortality rate of 50% within five years and 90% 
within 10 years of diagnosis (Audi et al., 2017). This outcome should compel cardiologists to 
talk with patients about what to expect in advancing illness (Audi et al., 2017); however, only 
15% of cardiologists believe that it is their responsibility to handle ACP conversations for heart 
failure patients (Chandar et al., 2017). One study found that participants with fewer than two 
years to live did not understand the progression of heart failure or know that the disease is 
terminal (Hupcey, Kitko, & Alonso, 2016). These collective findings make prioritizing ACP 
conversations in this population important.  
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 Heart failure is a common, complex disease, and as such, cardiology clinicians have 
created heart failure clinics within their larger cardiology practices. However, it is not common 
practice for most heart failure clinics to have a protocol for ACP to identify and engage 
appropriate patients earlier in the course of care. The purpose of this project was to develop a 
protocol to improve the process of increasing ACP conversations with patients with heart failure. 
The protocol was designed for providers who want to implement or improve ACP for persons 
with heart failure in an outpatient heart failure clinic. The entire protocol is available in 
Appendix A and a one-page algorithm of the project is available in Appendix B.  
Background and Significance 
Risk Factors for Heart Failure 
Heart disease is currently the leading cause of death in the United States and remains the 
number one or two leading cause of death since 1910 (CDC, n. d.; CDC, 2017b). While heart 
failure is a subset of heart disease, many of the risk factors for heart failure are other forms of 
heart disease (Benjamin et al., 2017). Risk factors include coronary heart disease (CHD), 
hypertension (HTN), diabetes (DM), obesity and smoking. One third of Americans are classified 
as stage A heart failure, or those with predisposing risks for developing the disease (Benjamin et 
al., 2017).  
 Coronary heart disease. Coronary heart disease occurs when plaque builds up inside the 
vessels that supply the heart with blood (American Heart Association [AHA], 2018). 
Chronically, this can lead to a narrowing of the vessels, which can slowly decrease and 
eventually stop blood flow to the heart. Acutely, the plaque can break and cause an immediate 
cessation of blood flow to the heart. Both avenues lead to a myocardial infarction (AHA, 2018). 
Coronary heart disease affects 16.5 million Americans over 20, with a prevalence of 6.3% 
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(Benjamin et al., 2017). The direct and indirect cost of CHD was just short of $200 billion in 
2013; costs are projected to increase 100% by 2030 (Benjamin et al., 2017).  
Hypertension. Hypertension is defined as a systolic blood pressure ≥ 140 mmHg or a 
diastolic blood pressure of ≥ 90 mmHg or reported use of an antihypertensive medication 
(Benjamin et al., 2017). The prevalence of HTN was estimated to be 34% from 2011-2014, 
affecting 85 million adults older than 20. While HTN does not cause death outright, it 
contributes to morbidity and mortality and is a risk factor for heart disease. Risk factors include 
age, race/ethnicity, family history, obesity, smoking, sleep apnea, and high intake of fat, sodium 
and alcohol. The lifetime risk of someone developing heart failure is 1.6 times greater for those 
with HTN compared to those without HTN (Benjamin et al., 2017).  
Diabetes.  A hemoglobin A1C > 6.5% or a fasting blood sugar > 126 mg/dL is indicative 
of diabetes. It is estimated that 9.4% of the population has diabetes, equating to 30.3 million 
people. Of those, 7.2 million of them have undiagnosed diabetes (CDC, 2017c). Furthermore, 
another 33.3% of Americans have prediabetes, which may progress into type 2 diabetes without 
lifestyle modifications (CDC, 2017c).  Individuals with diabetes are more likely to develop heart 
disease and are two to four times more likely to die from heart disease than those without 
diabetes. In relation to heart failure, diabetes alone qualifies individuals for American Heart 
Association/American College of Cardiology (AHA/ACC) stage A heart failure (Benjamin et al., 
2017). Studies have shown that those with diabetes are at increased risk of developing heart 
failure (Benjamin et al., 2017). 
Obesity. Obesity is defined as a body mass index (BMI) of > 30.0 (Benjamin et al., 
2017). Since 1999 the prevalence of obesity has continued to increase, and current data reveals 
that 37.7% of Americans are obese (Benjamin et al., 2017). Obesity is associated with chronic 
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health conditions such as DM, HTN, CHD, dyslipidemia, stroke, obstructive sleep apnea, as well 
as increased risk of mortality. The lifetime risk of developing heart failure for someone with a 
BMI > 30.0 is double compared to someone with a healthy BMI of < 25. While the risk factors 
for obesity are well known, many Americans do not perform the recommended amount of 
physical activity or eat according to dietary recommendations (Benjamin et al., 2017).  
Smoking. Most recent estimates suggest that 16.7% of men and 13.7% of women over 
age 18 smoke (Benjamin et al., 2017). While this has decreased since 1965, it is still moderately 
high despite the knowledge that smoking is harmful to health. Smoking itself does not cause 
heart failure but is a risk factor for developing CHD (Benjamin et al., 2017). It also has a 
synergistic effect with HTN and diabetes, both of which increase the risk of heart failure. 
Smoking cessation is proven to reduce the risk of morbidity and mortality for those with and 
without cardiovascular disease (Benjamin et al., 2017).  
Heart Failure Symptom Burden, Disease Trajectory and Patient Understanding 
 Within the past 10-15 years, the research literature has shown that heart failure patients 
have lower quality of life and a high symptom burden (Lewin & Schafer, 2017; Xu et al., 2015). 
Symptoms of heart failure include persistent dyspnea, pain, anxiety, fatigue, edema, nausea, 
altered mental status, insomnia and depression (Lewin & Schafer, 2017; Xu et al., 2015). As the 
disease progresses, many of the symptoms become refractory to treatment, increasing the 
symptom burden. A 2015 observational cross-sectional study by Xu and colleagues compared 
symptom burden and quality of life scores between patients diagnosed with amyotrophic lateral 
sclerosis, chronic obstructive pulmonary disease and heart failure and found those with heart 
failure had the lowest quality-of-life scores.   
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Three concerning themes occur in the literature: (1) patients with heart failure do not 
understand the disease and often blame their symptoms on old age or other comorbid conditions 
(Hupcey et al., 2016; Klindtworth et al., 2015); (2) patients do not understand this disease will 
progressively worsen over time and result in death (Glogowska et al., 2016; Hupcey et al., 2016; 
Klindtworth et al., 2015); and (3) caregivers do not understand the severity of the disease and 
cannot recognize when their loved one is dying (Alonso, Hupcey & Kitko, 2017). Further 
complicating these themes is the variable disease trajectory of heart failure. Lack of 
understanding and variable illness trajectory contributed to provider, patient, and caregiver 
overestimation of patient survival time (Alonso et al., 2017; Meyers & Goodlin, 2016).  This 
impacted patient opportunity to discuss ACP with his or her provider (Glogowska et al., 2016).   
Barriers to Advance Care Planning 
 Numerous barriers to ACP were identified in the literature. Resource barriers included 
lack of time, training, confidence in handling this difficult topic, knowledge regarding available 
tools and staff shortage (Dube, McCarron & Nannini, 2015; Waldrop & Meeker, 2012). Some 
barriers could be rectified with restructuring of appointments and training staff. However, the 
two barriers that were not easily overcome included the reluctance to discuss realistic prognosis 
and the clinician’s attitude of “that isn’t my problem.” Clinicians and patients alike do not want 
to discuss death, and so each wait for the other to bring up the topic (Alonso et al., 2017; Hupcey 
et al., 2016; Meyers & Goodlin, 2016). Other providers, including cardiologists, considered 
treatment as their only responsibility or expected someone else would have the conversation, and 
so the topic was never broached (Chandar et al., 2017). Chandar and colleagues (2017) found 
this to be true for cardiologists; when compared to primary care physicians and oncologists, only 
15% of cardiologists thought ACP conversations were their responsibility, 57% rarely or never 
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performed them, and 75% thought it was the job of the primary care physician.  Finally, some 
clinicians did not broach the subject because they did not want to “take away hope” (Meyers & 
Goodlin, 2016). They feared a conversation about death and dying would increase anxiety, 
depression, and family distress (Bernacki & Block, 2014). 
Benefits of Advance Care Planning 
 Benefits of ACP were well-documented. Timely ACP conversations are associated with 
reduced hospital admissions, decreased inappropriate healthcare usage, decreased cost of care in 
last year of life, and less aggressive care near death (Chandar et al., 2017; Meyers & Goodlin, 
2016). ACP can decrease patient anxiety, increase satisfaction with care, improve quality of care, 
respect patient autonomy and dignity, and improve communication (Dube et al., 2015; Meyers & 
Goodlin, 2016; Weathers et al., 2016). Advance care planning is also beneficial to family 
members involved in the conversation as it lessens the burden of making a difficult decision by 
knowing what the person would choose for medical care. Knowing what the patient desires at his 
or her end-of-life gives caregivers more peace about making the right decision (Dube et al., 
2015). 
Changes in Reimbursement 
 Advance care planning conversations can be time-consuming. A significant and often-
cited barrier to ACP was the lack of reimbursement for a process that could take considerable 
time (Sonenberg & Sepulveda-Pacsi, 2018). However, in January of 2016, Medicare eliminated 
this barrier and began paying for time spent performing ACP services (Moore & Hays, 2016). 
There are now two billing codes for this service: 99497 and 99498. A 99497 is for the first 30 
minutes and includes discussing ADs and patient desires (Moore & Hays, 2016). The AD forms 
do not need to be completed to bill for the conversation. This conversation is flexible as it can be 
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performed by a physician, advanced practice registered nurse (APRN), physician assistant or 
registered nurse (RN), and billed during multiple encounters. It must be face-to-face, but it can 
be with the patient, family member(s), and/or surrogate (Moore & Hays, 2016; Sonenberg & 
Sepulveda-Pacsi, 2018). A 99498 is used for each additional 30 minutes of counseling time 
spent. The codes can be billed as a stand-alone visit or added onto a normal patient visit, but if it 
is added on it must be in addition to the evaluation and management time (Moore & Hays, 2016). 
The 99497 counts as 2.40 relative value units (RVUs), which is about $85.99. The 99498 counts 
as 2.08 RVUs, about $74.52 (Moore & Hays, 2016).  
Advance Care Planning Across the Lifespan 
 It is estimated that 30-50% of middle aged to older adults have completed some form of 
AD (CDC, 2017a; Stevenson & O’Donnell, 2015). However, the rates are lower in patients with 
heart failure. A study examined 24,000 hospitalized patients with heart failure and found only 
12.7% had a documented AD (Stevenson & O’Donnell, 2015). Patients were found to be seven 
times more likely to complete an AD if an ACP discussion took place (Van Scoy et al., 2016).  
Clinicians often fear that having an ACP conversation will increase anxiety, depression 
and take away hope; however, the literature shows this fear is lacking in evidence (Bernacki & 
Block, 2014). Nevertheless, repeated qualitative studies with patients and caregivers alike echo 
frustration with providers for a lack of open communication about these topics (Fitzsimmons et 
al., 2019; Gusdal, Josefsson, Adolfsson & Martin, 2016; Klindtworth et al., 2015; Stevenson & 
O’Donnell, 2015). Many patients feel open communication is not provided and are not satisfied 
with their care in this area (Apatira et al., 2008; Klindtworth et al., 2015). The progression of the 
disease and recurrent exacerbations should trigger a patient and family needs assessment 
(Meyers & Goodlin, 2016).  
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Advance Care Planning with Heart Failure Patients 
 The variability of heart failure disease progression makes it difficult for clinicians to 
know when the “right time” is to have ACP discussions (Meyers & Goodlin, 2016). In a 
systematic review, Meyers and Goodlin noted that 50% of heart failure patients stated they 
would prefer to receive terminal care at home, but only 25% had that opportunity. Klindtworth et 
al. (2015) discovered a similar theme; older patients wished for a quick, peaceful death and 
desired to die at home. Death at home was not discussed as an option for patients.  
 In any patient population, most ACP conversations occur late in the progression of the 
disease, often when treatment options are no longer available or effective (Chandar et al., 2017). 
However, most heart failure patients die before reaching end-stage heart failure (Whellan et al., 
2014). Patient-centered care includes communicating with patients about their values and goals 
and explaining interventions that align with those goals (Whellan et al., 2014). Completing ACP 
early during the disease prepares patients and families for effective decision making for the 
overall course of the disease and possible future device treatments, such as pacemaker or 
implantable cardio-defibrillator (ICD) placement (Waldrop & Meeker, 2012).  
Project Aims 
This quality improvement project developed and evaluated an evidence-based protocol 
for use in an outpatient heart failure clinic to improve the ACP process. This process was created 
by performing a literature and resource review, evaluating and analyzing the findings, and using 
clinical experts as reviewers.  
Theoretical Framework 
 The theoretical framework for this project is the Trajectory Model by Corbin and Strauss 
(Robinson et al., 1993). Corbin, a nurse, and Strauss, a social scientist, developed this model 
after over 30 years of research in chronic illness management (Robinson et al., 1993). 
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“Trajectory” is the main concept and encompasses all aspects of an individual having a chronic 
illness, not only the physical (Robinson et al., 1993). “Biography” is an individual’s identity, 
including his or her past experiences and how those affect his or her choices today. “Trajectory 
projection” is the future of the illness and the course it generally takes. The model has nine 
phases that reflect the various stages an individual will experience while having a chronic disease 
(Corbin, 1998). This model accounts for the difficulties that arise in managing chronic illness 
and what individuals experience while adjusting to their illness. This theory is well-matched for 
heart failure because the nine phases of the theory reflect an individual’s disease trajectory 
through heart failure and account for the extreme variability of each patient. This theory is 
appropriate for ACP because the theory concludes with the dying process and acknowledgement 
of death (Robinson et al., 1993).  
Methods 
Design 
A review of the literature was performed to assess current evidence for ACP protocols 
and associated subjects. After the literature search, the evidence was analyzed, evaluated and 
synthesized by using a matrix, and then developed into a protocol. Two cardiology providers 
evaluated the protocol using a modified Appraisal of Guidelines for Research and Evaluation II 
(AGREE II) tool. They were also asked additional qualitative questions regarding 
implementation feasibility, protocol usefulness, and suggestions for improvements. The feedback 
from the evaluation was analyzed and necessary changes made to the protocol. 
Human Subject Protection 
Institutional Review Board (IRB) approval was obtained from University of Kansas 
Medical Center before beginning this project. Informed consent was not sought because this is a 
quality improvement project and no patient information was collected. Protocol evaluation was 
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performed by two providers in separate outpatient cardiology clinics who were willing to assist 
in the project. There was no direct interaction with patients. Information obtained during the 
evaluation phase was kept on a secure computer at University of Kansas Medical Center. 
Literature Search and Strategy 
 A literature search was performed between September 2018 and January 2019 using 
databases including CINAHL, PubMed, Cochrane, and Medline. Keywords for the literature 
search consisted of advanced care planning, end-of-life conversations, advanced directives, heart 
failure, congestive heart failure, cardiac failure, chronic heart failure, living wills, end-of-life 
wishes, protocol, guidelines, procedure, practice, policy, implementation strategies, and quality 
improvement. Higher level of evidence articles (meta-analysis, randomized controlled trials) 
were sought and given preference over lower evidence articles (expert opinion, case study). 
Article inclusion criteria consisted of English language, full text available and the initial search 
was limited to the past five years. The search was extended to 20 years, yet no articles focused 
on implementing or creating protocols to increase ACP conversations. A matrix was created to 
assess evidence quality and assist in evidence synthesis.  
Search Results 
 A total of 1,833 articles were identified using the search terms; however, no articles 
focused on implementing or creating pathways/protocols to increase ACP conversations in 
outpatient clinics. Three articles proposed timing of ACP conversations with heart failure 
patients; one a consensus statement from the AHA (Allen et al., 2012), and two editorials, one of 
which referenced the AHA article and other editorial (Dunlay & Strand, 2016; Lum & Sudore, 
2016). Eighty-seven articles were chosen from the 1,833 articles identified during the literature 
search. These articles were full text and selected based on title and abstract information that 
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included advanced care planning information such as implementation, barriers, advantages, 
finances, administration and tools and heart failure information including ACP in the heart 
failure population, billing and coding, caregiver and patient perception of heart failure and 
disease trajectory. The articles reviewed fell into 6 categories or a combination of: 1) general 
ACP information (barriers, benefits, documentation, etc.) and its importance; 2) the difficulties 
of performing ACP in the heart failure population; 3) patient and caregiver understanding of 
heart failure and/or ACP; 4) clinician perception of ACP and its difficulties; 5) 
increasing/evaluating ACP through a specific tool/intervention; 6) and implementing palliative 
care into heart failure. Article evaluation through matrix use included those that assessed 
increasing ACP through a specific tool/intervention (Appendix C).  
Protocol Evaluation 
Protocol Evaluators  
After the protocol was developed, cardiology providers were invited to evaluate the rigor, 
clarity, and applicability of the protocol using a modified AGREE II tool. In addition, the 
providers were asked for their opinion regarding the feasibility of implementing the protocol in 
their clinic. These providers were selected from a convenience sample known to the project 
director. 
Three cardiology providers were asked to participate in the project and all accepted. Each 
provider was from a different outpatient cardiology clinic. There were no stipulations regarding 
size of practice, provider title (M.D., N.P., P.A.), how many providers are at the practice, or how 
many patients the provider cares for daily. Clinicians were contacted in January of 2019 via 
email. The email included an explanation of the project and inquired if he/she was willing to 
participate in evaluating the protocol. After the quality improvement protocol was finalized, a 
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reiteration of the project, the protocol, and an explanation of the modified AGREE II tool was 
sent to the participants.     
Protocol Evaluation Tool 
The AGREE tool was developed to provide clinicians with an instrument to 
methodologically assess practice guideline quality (AGREE Next Steps Consortium, 2017). An 
international team of guideline developers and researchers developed the first tool in 2003 and 
made updates in 2009, creating the AGREE II tool (Brouwers et al., 2010).  Any provider can 
use the AGREE II tool. It takes about 1.5 hours to complete and comes with a manual to assist 
the appraiser during the review process. It is recommended that at least two, but preferably four, 
appraisers review the guideline in question (Brouwers et al., 2010). The AGREE II focuses on 
the methodological issues present during guideline development and is unable to evaluate the 
validity guideline recommendation validity (Brouwers et al., 2010). This is a target point of the 
next phase of AGREE tool development. The AGREE II is a 23-item questionnaire that uses a 7-
point Likert scale and is divided into 6 domains (Brouwers et al., 2010).  
The AGREE II manual has information on how to score the document in question and 
interpret those scores. Once all appraisers score the document using the Likert scales the data is 
added together by domain and then converted into percentages by using the maximum possible 
score for that domain (AGREE Next Steps Consortium, 2017). This is dependent upon how 
many appraisers score the document and if all the questions are used in each domain. It is 
suggested by the manual to use a cut off > 70% for high quality documents. See page nine in the 
AGREE Next Steps Consortium instruction manual (2017) for a complete analysis. 
The percentages should not be combined into a single overall score but should remain 
separate by domain (AGREE Next Steps Consortium, 2017). There are several different ways to 
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interpret the domain scores once a percentage is obtained for each. The first way is to prioritize 
one domain over others. This can be decided based on consensus between those appraising the 
document or predetermined by an individual directing the guideline review. The second way is to 
consider all domain scores, i.e. the document must score > 70% in all domains to be considered 
high quality. The third way is to evaluate for percentage changes over time by comparing the 
guideline in question to its older counterpart (AGREE Next Steps Consortium, 2017). 
The original AGREE II tool was modified to fit the purposes of this quality improvement 
project. Each question was evaluated for its applicability to this project and either removed or 
edited as needed. “Guideline” was changed to “protocol” on the scoring sheet. The user manual 
has information on what to consider and criteria used to score each item. The original numbers 
for each item were kept, assisting evaluators in using the manual and modified scoring sheet 
together. The purpose of using this tool was to obtain a quantitative evaluation of the protocol 
and assess for areas of improvement. Permission was not obtained as the AGREE tool can be 
modified with proper citation as noted on the AGREE Enterprise website (AGREE, n.d.). The 
modified AGREE II tool scoring sheet can be found in Appendix D.  
Protocol Evaluation Process 
 Protocol evaluation was conducted through both quantitative and qualitative methods. 
The quantitative information was obtained using the modified AGREE II tool. The qualitative 
information was obtained using a self-developed questionnaire regarding protocol feasibility 
(Appendix E). In addition, demographic characteristics of protocol evaluators were also 
collected, including title, years of experience as a cardiology provider, location of clinic (rural 
vs. metropolitan), age and gender (Appendix E). 
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 After the modified AGREE II was returned it was scored and the scores were compared 
between providers. If scores had a difference of greater than 20% an assessment would have 
been conducted. Areas with the lowest scores were evaluated for possibility of improvement. 
The questionnaire for protocol feasibility was reviewed and analyzed by the project coordinator 
without identifying changes needed in the protocol. 
Results of Protocol Evaluation 
Evaluator Demographics 
 Three cardiology providers were asked to evaluate the protocol and all three accepted. A 
time frame of one month was given for reviewing and scoring the protocol. A reminder email 
was sent to the evaluators one week before the deadline. Two of the three evaluators returned 
their completed information to the project coordinator within the specified time frame. The 
project coordinator contacted the third provider without response.  
 Both evaluators were APRNs in separate practices in a metropolitan area. Evaluator A 
was male, age 37 with five years of experience in a large heart failure clinic serving more than 
1800 heart failure patients. Evaluator B was female, age 45 with 20 years of experience in 
cardiology and coordinated a heart failure clinic for 400 patients.   
Modified AGREE II Results 
 Scores were calculated by the project coordinator. Both evaluator Likert scores were 
added together by domain and converted to percentages by using the maximum possible score 
for that domain. Full scoring instructions can be found in the AGREE II user manual (AGREE 
Next Steps Consortium, 2017). A score of >70% in all domains was considered high quality. The 
scores for each domain are as follows: 
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Domain 1: Scope and Purpose 90% 
Domain 2: Stakeholder Involvement 88% 
Domain 3: Rigor of Development 86% 
Domain 4: Clarity of Presentation 79% 
Domain 5: Applicability 92% 
A comparison between the two evaluators showed similar scores given in each domain. 
The scores did not differ by more than 20%, therefore further assessment did not need to be 
conducted. 
Questionnaire Results 
 Four questions were asked the providers.  
1) How feasible would protocol implementation be in your clinic? 
2) How could the protocol be made stronger/more complete? 
3) What are the barriers you see to implementing a protocol such as this? 
4) Do you think the protocol would be useful in your clinic? 
Both evaluators agreed protocol implementation would be feasible in a heart failure clinic 
but would be more achievable in a small setting because of patient volume. Neither evaluator 
shared suggestions to improve the protocol. Identified barriers included administration, 
additional support staff time needed to identify and schedule patients, and length of appointment 
times needed for ACP discussions. Despite the barriers, both evaluators felt that the protocol 
would be useful in their respective clinics.  
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Discussion 
 Through an evidenced based literature search data was gathered, analyzed and 
synthesized into the development of this protocol. Protocol evaluation occurred through two 
independent cardiology providers using the modified AGREE II tool and a qualitative 
questionnaire. A score of > 70% was considered high quality for the original AGREE II tool, and 
this standard was used for the modified AGREE II tool as well. Using the modified tool, each 
domain received a score of > 70%. This was higher than expected and the limitations discussed 
below factor into the scores.    
Domain 4: Clarity of presentation received the lowest score. In the original AGREE II 
tool, there are three items in this domain. For this project, one item was removed due to 
applicability. This domain scored lower because of the imprecise nature of this topic, the 
individuality of each patient situation, provider style and resource availability. It would be 
difficult to give specific recommendations when patient-care should be tailored to individual 
need. The protocol contains high level recommendations but breaks down when specific 
situations are generated.  
Domain 5: Applicability scored the highest with 92%. The original AGREE II tool has 
four items in this domain and was one removed for the modified tool. This domain considers the 
barriers and benefits of implementation, tools and advice on how to put recommendations into 
practice and resource issues that could potentially arise with implementation (AGREE Next 
Steps Consortium, 2017). This domain scored the highest because the protocol contains 
strategies and tool for implementation, training methods for additional provider education, and 
resources for commonly occurring barriers. 
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Limitations 
 The AGREE II tool recommends using two to four evaluators to score a guideline, with 
favor given to including more evaluators. We attempted to include three evaluators for this 
protocol; however, given time constraints one of the evaluators who originally agreed to 
participate was not able to complete the task. Having more evaluators would improve the review 
process. This may have skewed the results of the modified AGREE II tool, contributing to the 
higher than expected domain scores. This could be due to the theoretical nature of the project. If 
tasked with implementation, other providers would more than likely find ways to strengthen the 
protocol. Other limitations of protocol evaluation include similar clinic locations, convenience 
sampling and the professional relationship between the project coordinator and evaluators.  
 Project Improvements and Future Plans 
 One way this protocol could be improved upon is the application of an EMR to the 
process. The EMR could be utilized in a variety of ways, including triggering alerts for patients 
who do not have an AD, or who meet other stipulations decided by the project coordinator 
(recent hospitalizations/ER visits, late stage AHA/ACC classes, continued increases in diuretics, 
etc.), placing the AD in a common place all providers can find, or compiling a list of all patients 
needing ACP conversations. An additional way this protocol could be improved upon is in its 
evaluation: including more evaluators from different disciplines, different geographies, and with 
a different sampling method. 
 Currently there is no plan for implementation; however, this author would be supportive 
of any student (or provider) desiring to implement it as a QI project and is amenable to any 
adaptations needed for implementation. The author will discuss this opportunity with Doctor of 
Nursing Practice students he encounters in the future.  
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Summary 
There is clear agreement in the literature that ACP is important for patients and providers. 
There are no published studies on implementing ACP protocols in heart failure or primary care 
clinics, yet there is a growing awareness and interest in improving conversations and aligning 
goals with treatments. A protocol can be a starting point or resource for improving the process of 
identifying and implementing ACP in a heart failure clinic. This protocol must be used with a 
small, committed team of healthcare providers willing to begin this conversation with patients. 
There is so much about medicine that patients and family members do not understand, and we as 
healthcare providers need to do better, be better, for our patients. The goal guiding this project 
was to improve quality of life for heart failure patients through ACP. This protocol was created 
to begin this process, in the hopes that it, or something similar, would be implemented in a heart 
failure clinic, improving ACP for patients and providers alike. 
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Appendix A 
A Protocol to Increase Advance Care Planning Conversations in an Outpatient Heart 
Failure Clinic  
Assessment of Clinic 
 The assessment of the clinic is one of the most important parts of this process, as it will 
guide much of the QI project after the findings are reviewed. There may be more than one area 
needing improvement to facilitate ACP conversations. It may be possible to make all the changes 
at one time, or the changes may need to occur in steps. This will depend on the local 
environment of the clinic where the QI project is taking place. Clinic assessment consists of a 
chart review, informal interviews with providers, and reviewing clinic processes regarding ACP. 
This protocol is being developed for heart failure clinics, and as such, only patients with heart 
failure should be used for inclusion for the chart review. Initially, the entire clinic does not have 
to be included in the QI project. Choose a few providers who are willing to participate, and after 
the results are reviewed and improvements made the project can be expanded. 
 Chart Review. Advance care planning documentation and ADs have been used in the 
literature as a proxy for ACP conversations (Lum et al., 2018; Sudore et al., 2017). Using an 
electronic medical record, perform a chart audit for ACP documentation and the number of times 
ACP was billed by providers. Advance care planning documentation includes AD, a living will, 
DPOAHC, or TPOPP forms, and documented ACP discussions. The billing codes of 99497 and 
99498 indicate ACP billed by providers. Limit the search results to AD documentation received 
in the clinic. This chart review should occur at baseline and then at the end of the QI project. For 
example, if a period of six months is chosen for the QI project, then the retrospective chart 
review should go back six months for baseline data. After 6 months of implementation, the chart 
review can be completed again to compare results.  
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 Provider Interviews. An in-person interview should be performed with the providers 
participating in the QI project to assess how he or she performs ACP conversations and what 
triggers the provider to purposefully have a conversation. This author has created a questionnaire 
(Appendix F) to facilitate the interview which focuses on provider comfort, perception of 
appropriate timing, and format of ACP conversations he or she currently performs. Have the 
questionnaire present during the interview and record the answers on the sheet. At the end of the 
interview give the provider the opportunity to examine the document for accuracy and make 
necessary changes if any are needed. Other items to assessed are provider knowledge of where to 
find AD in the EMR and knowledge of how to bill an ACP session. 
Clinic Processes. The office staff included in identifying office processes will be those 
who interact with every patient (receptionist, scheduling, check out) and the medical assistants 
and or nurses of the providers used for the QI project. They will be asked two questions: “Do 
you ask every patient if they have an AD/DPOAHC?” and “What do you do if a patient tells you 
he/she has an AD/DPOAHC or presents you with one?” This information can be recorded and 
analyzed for consistency between staff and obtained to evaluate if any changes need to be made 
in clinic flow. Other processes to assess are clinic appointment time lengths, room size (to 
accommodate family members should the patient desire them to be in the conversation), and 
resources the clinic provides for patient education (if there is any).  
Timing Advance Care Planning 
 According to Lunney, Lynn, & Hogan (2002) there are four main categories of illness 
trajectories: sudden death, terminal illness, organ failure and frailty. Most patients with heart 
failure fall into the categories of organ failure or frailty. Patients in either of these categories will 
oscillate between times of wellness and times of decompensation, all the while trending 
downward toward death. The extremes of wellness and disease are more exaggerated for those in 
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the organ failure category. For patients and families, these extremes are emotionally, physically 
and psychologically exhausting; just as the patient seems to get better, there is another 
decompensation (Alonso et al., 2017; Fitzsimons et al., 2019) In terms of the organ failure and 
frailty trajectories, it is difficult for providers to pinpoint the “right time” to discuss ACP issues. 
The optimum time to discuss patient wishes/preferences is when he/she is stable; however, this 
does not always occur. 
 About 50% of patients with heart failure have a reduced ejection fraction (HFrEF) with 
the other half having a preserved ejection fraction (HFpEF) (Shah et al., 2017). Despite advances 
in treatment for those with HFrEF and difficulties in treatment for those with HFpEF, mortality 
rates remain equally high in both groups. It is often quoted that 50% of individuals will die 
within 5 years of diagnosis, however, Shah et al. (2017) found this number to be as high as 75% 
(Lewin & Schaefer, 2017). The one-year mortality for patients after their first hospitalization and 
for those experiencing NYHA class IV symptoms is 30% and 75% respectively (Chen-
Scarabellli, Saravolatz, Hirsh, Agrawal, & Scarabelli, 2015). In this disease, most patients do not 
survive long enough to be categorized with end-stage heart failure (AHA stage D) (Whellan et 
al., 2014). Despite this, most conversations about ACP do not occur until all treatment measures 
have been attempted, at the end of the illness trajectory. 
 Triggering Patient Conversations. It is impossible to predict which patients will die 
suddenly and which patients will reach end stage heart failure. While ACP is a topic that should 
be discussed more frequently and at specified points in a patient’s trajectory, the reality is quite 
different (Bernacki & Block, 2014; Dunlay et al., 2015; Klindtworth et al., 2015). The AHA 
consensus statement of 2012 and Dunlay & Strand (2016) give suggestions for important triggers 
of when ACP conversations should take place. The triggers include  
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 1) annual visits 
 2) repeated hospitalizations/ER visits  
 3) change in function/health status (loss of ADLs, falls, change in living situation) 
 4) disease progression (increase symptom burden/decreased QOL) 
 5) new comorbid conditions 
 6) serial increases in maintenance diuretic doses  
 7) ICD shocks (Allen et al., 2012) 
 In addition to the above suggestions, those with end stage heart failure (AHA stage D or 
NYHA stage IV), and any patient diagnosed with heart failure who does not have any ACP 
documentation should be a priority for an ACP conversation.   
 Providers should be aware of and educated regarding these triggers at the beginning of 
the QI project. It may be helpful to have the medical assistant or RN fill out a form similar to the 
template in Appendix G while rooming the patient. This will give the clinician real time 
information regarding patient AD status and need for ACP conversation, and may keep ACP in 
the front of the clinician’s mind.  
 Heart Failure Prediction Tools. Some clinicians prefer to use a prediction tool to 
evaluate the need for an ACP conversation. There are several prediction tools available for 
clinicians, each having their advantages and pitfalls.  
 One of the most popular tools is the Seattle Heart Failure Model, which is a prognostic 
tool used to estimate a patient’s 1, 2 and 3-year survival (Levy et al., 2006). This tool has been 
validated by multiple cohorts (Levy et al., 2006). It is available as a calculator free online 
through the University of Washington (University of Washington, 2017). While unable to predict 
the future, this model provides additional information for the clinician on the urgency of 
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scheduling an ACP conversation with a patient. The online calculator can be found at the 
following link: https://depts.washington.edu/shfm/?width=1536&height=864. 
The Cardiovascular Medicine Heart Failure Index (CVM-HF) is another prognostic tool 
for clinicians, but this tool calculates odds mortality instead of survival (Senni et al., 2006). It has 
been validated in heart failure populations and can be quickly calculated using a pen and paper. 
The table can be found in Treece et al., 2018.  
The “Surprise Question” is a simple, quick, albeit semi effective tool used to evaluate 
patients for those clinicians who cannot (or do not) want to calculate using a tool. It is “Would it 
surprise you if this patient were to die within the next year?” It is based on clinician gestalt and 
during systematic reviews has been found to be semi-effective at predicting patient mortality 
(Downar, Goldman, Pinto, Englesakis, & Adhikari, 2017; White, Kupeli, Vickerstaff & Stone, 
2017). This question performs better in the cancer population and when used by clinicians 
instead of nurses. One study modified the question for the primary care setting to include patients 
who would die within the next two years (Lakin et al., 2017). It is generally agreed that this 
should not be the only tool used to evaluate patients but should be used in conjunction with 
others to evaluate patient mortality (Downar et al., 2017; White et al., 2017). This question is 
used as part of a heart failure palliative care consult at University of Kansas Health System (S. 
Sanders, personal communication, January 8, 2019). 
 The ePrognosis tool, also known as the Gange index, is a free online tool that combined 
the Charlson and Elixhauser measures to predict one-year mortality in community dwelling 
adults ≥65 (Gange, Glynn, Avorn, Levin, & Schneeweiss, 2011). The benefit of this tool is it 
considers other comorbidities and medical conditions in addition to heart failure to predict an 
individual’s mortality risk. This tool was validated in a cohort of 120,679 Medicare enrollees in 
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Pennsylvania (Gange et al., 2011). The tool can be found at the following link: 
https://eprognosis.ucsf.edu/gagne.php. 
Proper Documentation of Visit 
 In order to receive payment, there are certain aspects that must be included in ACP 
documentation. To summarize from the literature review, the ACP conversation must be face-to-
face, can be performed by a physician, APRN, physician assistant or RN, billed during multiple 
encounters, and can be with the patient, family member(s), and/or surrogate (Moore & Hays, 
2016; Sonenberg & Sepulveda-Pacsi, 2018). 
 Time Requirements. As 99497 and 99498 are time-based codes, the time spent 
conducting the ACP conversation must be included. The 99497 code is for the first 30 minutes of 
the conversation and 99498 for any additional 30 minutes. To fulfill the time requirements, the 
clinician must past the midpoint of the time requirement. Thus, to bill for a 99497, the 
conversation must have taken at least 16 minutes (Davies, 2017). To bill for a 99498 when 
attached to a 99497, the conversation must have taken a total of at least 46 minutes (30 minutes 
for the 99497 and 16 minutes for the 99498). If this is being added onto an Evaluation and 
Management (E&M) visit, this time must be in addition to the E&M time and not in lieu of it 
(Moore & Hays, 2016). 
 Example documentation of the following would fulfill the requirement for 99497: “I have 
spent more than 16 minutes in face to face discussion of patient condition, prognosis, treatment 
goals, and advance care planning with the patient and/or surrogate decision makers” (R. 
Studnicka, personal communication, January 11, 2019). Example documentation of the following 
would fulfill the requirement for 99498 when attached to a 99497: “I have spent a total of 46 
minutes in face to face discussion of patient condition, prognosis, treatment goals, and advance 
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care planning with the patient and/or surrogate decision makers” (R. Studnicka, personal 
communication, January 11, 2019).  
 Note Requirements. Further documentation includes individuals who were present for 
the ACP conversation, details of the conversation with patient/family quotations included, the 
outcome of the conversation, possible documents completed during the conversation, and other 
documents available that further outline patient/surrogate wishes (MOLST/POLST/TPOPP). 
Details of the conversation should include general information, such as the patient’s values and 
preferences, fears and concerns, and specifics regarding life sustaining treatments, future 
hospitalizations, and hospice care (Dingfield & Kayser, 2017; R. Studnicka, personal 
communication, January 11, 2019). Patient illness, disease trajectory and poor prognosis should 
also be included (Dingfield & Kayser, 2017). An example template and an example note can be 
found in Appendices H & I.  
Common Barriers to Advance Care Planning 
 Barriers to ACP are well documented in the literature and include lack of time, training, 
knowledge regarding available tools, staff, and clinician or patient discomfort with the subject 
(Dube et al., 2015; Waldrop & Meeker, 2012). While compensation for ACP conversations is 
now available, if not already in place at a clinic, there can be considerable overhead in order to 
train staff and restructure clinic flow. Barriers to ACP and resources for barrier removal will now 
be discussed. 
 Clinician Training. Lack of clinician training is one of the most oft cited reasons ACP is 
not completed (Alonso et al., 2017; Hupcey et al., 2016; Lum & Sudore, 2016; Meyers & 
Goodlin, 2016). Fortunately, there are many resources available for clinicians to obtain training 
in this subject. Some are free, while others require payment.  
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The Serious Illness Conversation Guide (SICG) (Appendix J) is a tool that can be used to 
guide ACP conversations. Ariadne Labs developed the SICG through a national panel of experts 
that included patients and had providers from fields such as oncology, palliative care, internal 
medicine, cardiology, pediatrics, and surgery (Bernacki et al., 2015). Following development, the 
SICG was presented to the Patient and Family Advisory Council and given to a marketing firm 
to perform focus groups with patients, families and providers (Bernacki et al., 2015). Each group 
gave feedback for terminology and format refinement. Next a pilot group of 26 providers used it 
in practice and gave 3 cycles of feedback until the final guide was produced (Bernacki et al., 
2015). The SICG can be downloaded for free when individuals sign up for Ariadne Lab’s free 
membership. After signing up, clinicians can join different community groups. This gives access 
to a greater number of resources that go in depth regarding the SICG, its development and usage, 
tips for organizational implementation, a community forum to discuss questions with other 
clinicians, and videos and webinars. 
There is a one-hour webinar available on YouTube that gives an overview of how to use 
the SICG when talking with patients that is available here: 
https://www.youtube.com/watch?v=vMHe0q2gpCI&t=7s. There are also two shorter videos that 
demonstrate the use of the SICG which can be found here: 
https://www.youtube.com/watch?v=xLl1HlCcNYM and 
https://www.youtube.com/watch?v=fhwa9f5O_U4.  
Vital Talk is a nonprofit organization developed to disseminate their research on 
communication to clinicians (Vital Talk, 2018). They have developed online and in-person 
training courses and tools to better assist clinicians in communicating with patients about 
delicate topics. Their tools range from basic to in-depth, with the basic consisting of free videos 
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and worksheets for clinicians to view on their website and more in-depth courses having a cost 
attached. The free videos include Vital Talk’s core techniques and tools. The Disclose Serious 
News section is 5 videos that total in 4 minutes and 30 seconds. The Address Goals of Care 
section is 10 videos that total in about 16 minutes. The Conducting a Family Conference section 
is two videos totaling about 7 minutes. Other free sections include Establish Rapport, Offer 
Prognostic Information, Track and Respond to Emotion, Defuse Conflicts, Stay Strong, Bear 
Witness to the End, and Cultivating your skills (Vital Talk, 2018). Most sections have free 
guides that can be printed for clinician use during ACP conversations. The guides are also freely 
available on the Vital Talk apps (on Apple and Android). Cost for the courses range from a $110 
online course, a $500 workshop, and a $2,500 conference that allows the clinician to become a 
trainer (Vital Talk, 2018).  
The Center to Advance Palliative Care (CAPC) is another clinician resource. Established 
in 1999, the CAPC was created to improve patient care and assist health care organizations in 
developing palliative care programs throughout the U.S. (Center to Advance Palliative Care 
[CAPC], 2019).  
They provide training through courses, webinars, CMEs and CEUs, and discussion forums. For 
access to their products there is one annual membership fee and then all individuals of the 
organization have access. The annual fee for an outpatient clinic is $3,500 (CAPC, 2019).  
 Patient Comfort. Part of ACP is assessing patient readiness. Some patients need more 
time than others to process their thoughts and prepare for an ACP conversation. Using the list of 
patients who do not have ADs, which was compiled during the assessment, prioritize them 
according to the above suggestions. During the appointment reminder message let the patient 
know that there is a QI project going on, all patients are being assessed for an AD, and he/she did 
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not have one (or it needs to be updated). A discussion regarding ACP will be conducted at 
his/her next appointment and the patient can bring family members to the appointment for the 
discussion if he/she chooses. Ariadne Labs, who created the SICG, has also created a pre-visit 
letter that can be mailed or emailed to selected patients to assist in patient readiness (Appendix 
K). This is available at no cost for those who have signed up for their free membership. 
 If the office has chosen a tool to use that is asynchronous (see patient resources below) to 
the appointment, this would also be the time to tell the patient to review the tool prior to coming 
to the appointment. This way, any questions can be answered by the clinician.  
 If the patient is hospitalized and the clinic is associated with the hospital, many clinics are 
notified that the patient is in the hospital and is scheduled for a follow up clinic appointment 
within 2-4 weeks. The time to introduce this information would be at discharge from the hospital 
so the patient could review the information before the following appointment. One of the team 
members can meet with hospital case management to ensure the information is passed along to 
the patient.  
 Patient Resources. There are two types of resources for patients: synchronous 
(viewed/read in office) and asynchronous (view at home/at the patient’s leisure). Each have their 
advantages and disadvantages, but both can be useful in increasing patient understanding and 
preparedness for participating in an ACP conversation. Some end with the production of an AD. 
Five Wishes is a program created by the nonprofit organization Aging with Dignity 
(Aging with Dignity, 2018). For $5.00 anyone can use their program to create an AD. It is user 
friendly, available online or as a hardcopy, and is easy for non-medical personnel to understand 
(Aging with Dignity, 2018).  There are also resources for providers, including an instructional 
video, conversation guide, and the ability to buy the Five Wishes document in bulk. Kansas is 
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one of ten states that requires patients to fill out an additional form after completing their Five 
Wishes document to make the information legally-binding. Their information can be found at 
https://fivewishes.org/Home  
 Making Your Wishes Known (MYWK) is an online tool that assists adults in completing 
an AD. Clinicians can also use MYWK to facilitate ACP conversations with patients. Making 
your wishes known has been found to increase ACP knowledge in patients, and patients have 
reported being highly satisfied with how the tool presents information and the accuracy of the 
final AD (Myers et al., 2018; Van Scoy et al., 2016). Their information can be found at 
https://www.makingyourwishesknown.com/default.aspx. 
 The Conversation Project is a public engagement initiative began by IHI with the goal of 
having all people express their end-of-life wishes so they can be respected (IHI, 2018b). They 
provide conversation starter kits for patients and family members to assist them in having an 
ACP discussion amongst themselves and with their clinicians. They also provide information 
about how to choose or be a healthcare proxy (IHI, 2018b). Starter kits are available for free if 
downloaded electronically and can be purchased as a hard copy for $3.05 each with a minimum 
of 25. An AD is not created at the end of the starter kit, however much of the necessary 
information needed for an AD is discussed in the starter kit. Their information can be found at 
https://theconversationproject.org/.  
 PREPARE for your care has a free online tool and easy to read AD which has been 
created, tested and validated by researchers (Lum et al., 2018; Sudore et al., 2007; Sudore et al., 
2017). The PREPARE tool is free and has videos and questions to assist patients in 
understanding ACP, how to make decisions, and incorporating their values into those decisions 
(Lum et al., 2018; PREPARE for your care, 2018; Sudore et al., 2017). There is also an easy-to-
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read AD that has been validated and is free for use after the video tool. The video tool and 
documents have been found to increase ACP conversations among family members and between 
patients and their clinicians and increase ACP documentation among clinicians (Lum et al., 
2018; Sudore et al., 2017). Individuals have rated the easy to read AD as easy to use, were highly 
satisfied, and would recommend it to others (Sudore et al., 2017). Their website is 
https://prepareforyourcare.org/welcome. 
 A dilemma in EOL care for some in the heart failure population is surgically placing an 
ICD, cardiac resynchronization therapy with defibrillator (CRT-D) or left ventricular assist 
device (LVAD) in a patient. While this sustains life, there is a great deal of confusion regarding 
when and how to shut off these devices (Whellan et al., 2014). While not an ACP tool, the 
Colorado Program for Patient Centered Decisions developed four decision aids pertaining to the 
ICD (initial and replacement of), CRT-D and LVAD. These decision aids can assist patients and 
clinicians in performing ACP conversations and making decisions with those that have these 
devices (McIlvennan, 2017). There is currently a RCT in six hospitals across the U.S. to evaluate 
the effectiveness of these decision aids (McIlvennan, 2017). They are available free of charge at 
https://patientdecisionaid.org/.  
The Quality Improvement Project 
General Quality Improvement Project Information 
 A quality improvement project (QI) is a continuous process of planning, testing and 
spreading change in an already established organization to better patient experience, improve 
processes, and increase the quality of care delivered in a measurable way (Agency for Healthcare 
Research and Quality [AHRQ], 2017b). This can be a daunting task, no matter the organization 
size. Research has indicated that the largest companies that function most effectively and have 
the most success in QI focus on the smaller, functional units that carry out the main activities of 
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the company. These smaller functional units are referred to as “microsystems” (AHRQ, 2017b). 
Examples of microsystems can include a patient’s care team (provider, nurses, medical 
technicians), staff who work with a specific patient population, or work areas linked together 
through processes (AHRQ, 2017b). Placing the QI project in the appropriate microsystem makes 
the task less intimidating and assists in identifying stakeholders and team members and 
determining the scale of the project (AHRQ, 2017b). Once the microsystem is identified, the 
beginning steps for a QI project can begin (Silver et al., 2016).  
 For the purposes of this project, the setting is an outpatient heart failure clinic. The 
microsystem is the individuals a heart failure patient would see and speak with during an 
outpatient visit. This includes the front office staff, medical assistants (MA), registered nurses 
(RN), and the clinician. Many clinicians have their own specific MAs or RNs assigned to them, 
and this could further concentrate the microsystem, focusing on a small number of clinicians and 
their respective MA and/or RN.  
 Determining stakeholders. A stakeholder is any person, group or organization who may 
be involved in the project or is interested in the outcome (Zaccagnini & White, 2017). These 
individuals can be on micro or macro levels and can affect, or be affected by, the project (Moran, 
Burson & Conrad, 2017). Identifying all stakeholders will assist in finding key individuals for 
the QI project team as well as detect those who could benefit/block the project (Moran et al., 
2017). A useful way to identify stakeholders is to brainstorm a list and categorize them into 
groups. A concept map is useful to visualize the stakeholders and the relationships between them 
(Silver et al., 2016). An example concept map can be found in Appendix L. 
 Once identified, stakeholders should be analyzed and categorized for interest in and 
power over the project (Silver et al., 2016). A 2x2 grid can be developed, with the y-axis used for 
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stakeholder power over the project and the x-axis used for stakeholder interest in the project, 
leading to four categories of individuals (Silver et al., 2016). An example grid can be found in 
Appendix M. 
 Forming the Team.  Once the stakeholders are analyzed, the roles of the QI team need to 
be filled. The following are general recommendations of team positions, but other positions may 
be needed depending on the organization and project (Department of Health and Human Services 
Health Resources and Services Administration [HRSA], 2011; Silver et al., 2016): 
• Team Lead: Person responsible for the day to day and overall management of the 
project. 
• Clinical Leader(s): Provider(s) who is/are responsible for championing the QI 
initiative in the targeted patient population. These persons understand how 
changes will affect different roles in clinic and are able to collaborate and 
influence those affected by QI changes. 
• Technical Expert(s): Individual(s) responsible for data entry and management and 
any technical assistance needed for the project (Example is electronic medical 
record (EMR) expert if changes need to be made in EMR). 
• Executive Sponsor: Individual in leadership who can support the QI project 
among administration, approve different aspects of project, approve supplies, and 
remove barriers, etc. 
 Physicians are an important part of the QI team because of their influence on healthcare 
outcomes, and are interested in quality, delivery and efficiency of care; however, there are many 
barriers to physician involvement including lack of time, financial incentives, and quality 
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improvement skills (Silver et al., 2016). If on the QI team, but not the team lead, physicians must 
try not to control the project (Silver et al., 2016).   
 Patients or family members can also play an important role on the QI team. Advantages 
to involving users of the healthcare system include challenging assumptions of the current 
system, energizing staff and focusing team members (Silver et al., 2016). Their main 
disadvantage is when patient/family involvement is mandated, making his/her involvement 
perfunctory to the team and insulting to the individual (Silver et al., 2016).  
 Particularly with the subject of ACP, it is especially important to find both executive and 
day-to-day leadership for the QI team in order to hold others accountable and track changes 
(Dixon & Knapp, 2018; Reidy et al., 2017). Dixon & Knapp (2018) conducted a qualitative 
interview with 12 institutions in 4 different countries and noted that ACP awareness and urgency 
declined quickly and significantly when senior level champions left their positions. 
 Selecting the QI Framework. An improvement framework provides structure and can 
help naturally guide the QI project (Silver et al., 2016). Several frameworks exist, and the most 
popular ones have overlap between them; therefore, choosing one should not be onerous (Silver 
et al., 2016). It is recommended that preference should be given to the framework team members 
have the most familiarity with.  
 Six Sigma. Developed by Motorola in the 1980s, Six Sigma uses quantitative tools to 
understand and control processes with the goal of improving quality and reducing variability 
(Moran et al., 2017; Silver et al., 2016). Quality improvement projects using Six Sigma use five 
phases, also known as the DMAIC process, to guide improvement (Moran et al., 2017). Different 
tools can be used in each phase to assist the project. 
1. Define- What is the improvement opportunity and how will success be measured 
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2. Measure- Determine current processes and gather needed data for a baseline 
3. Analyze- Use data to find cause of current problems and/or areas for improvement 
4. Improve- Make changes to current process based on findings from analysis; test the 
solutions 
5. Control- Ensure that changes can be sustained 
  Lean. Toyota is credited with developing this framework, which has two themes: respect 
for people and continuous improvement by eliminating waste (Silver et al., 2016). This 
framework does not use statistical analysis to reduce variation, and training in this method assists 
the user in skillful implementation. This framework applies best to situations where waste can be 
eliminated and speed, efficiency and flow are priorities that are directly observable (Silver et al., 
2016).  
 TeamSTEPPS. Developed by the U.S. Department of Defense and the Agency for 
Healthcare Research and Quality, TeamSTEPPS intent is to improve healthcare quality, patient 
safety, and team collaboration through free resource training (Moore, 2017). TeamSTEPPS has 
demonstrated success in a variety of healthcare settings (Moore, 2017). There are three phases to 
the TeamSTEPPS system (AHRQ, 2017a): 
1. Assess the Need 
2. Planning, Training and Implementation 
3. Sustainment 
 TeamSTEPPS is a useful framework because it is a comprehensive set of evidence-based 
curriculum designed to improve communication and improve quality in different settings 
(AHRQ, 2017a). The curriculum for this project would be the Office Based Care version. The 
curriculum is available as a classroom course, online course, or hybrid course. While all 
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resources are provided at no cost, the training for TeamSTEPPS is lengthy. The instructor guides 
are also provided, but this requires additional training as well.  
 Model for Improvement. Developed in the 1990s and popularized by the Institute for 
Healthcare Improvement, this model uses an algorithm focusing on the learned experience and 
purposeful action (Silver et al., 2016). Quality improvement is achieved by answering three 
questions (Institute for Healthcare Improvement [IHI], 2018a): 
1. What are we trying to accomplish? 
2. How will we know a change is an improvement? 
3. What changes can we make that will result in improvement? 
 This model is recommended because it is simple and efficient to use, and those with 
limited QI knowledge can utilize this model easily. It uses frontline staff to predict what changes 
will lead to an improvement. The main tool is the Plan-Do-Study-Act (PDSA) cycle, which is 
used to continually evaluate the changes made based on the how the original three questions 
were answered (IHI, 2018a; Silver et al., 2016). Using the PDSA cycle, individuals should not 
expect to find the perfect solution immediately. It allows users to test changes on a smaller scale, 
and if found useful, to expand those changes further (Silver et al., 2016). This model does not 
assist the users in identifying the cause of a quality of care problem and should be used with 
problems that have clear causes (Silver et al., 2016).  
 Obtaining Quality Improvement Approval. Some institutions require submission to 
IRB, while others to certain committees before beginning the project.  These regulatory bodies 
will ask for information regarding the QI project and will determine if the institution would like 
it to go forward, be revised, or not completed at all. Having an executive sponsor as a team 
member will assist in this area.  
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Assessing Implementation with PDSA Cycle 
 After implementing a QI initiative, it is important to evaluate what is and is not working. 
This PDSA cycle gives flexibility and fluidity throughout the quality improvement process and 
will assist in keeping the team on task to meet the end goals by answering the initial three 
questions. Team members should meet once a month to go through the PDSA cycle and make 
necessary changes in the project.  
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Appendix B 
Protocol Algorithm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Provider Discomfort/ 
Lack of Knowledge 
Interventions Include: 
-Vital Talk Training 
-SICG Training 
-Asynchronous Patient 
tool implementation 
Lack of Billing/ 
Documentation 
Interventions Include: 
-Review 99497 and 
99498 requirements 
-Give example note 
-Create ACP template 
Poor Clinic Flow 
Interventions include: 
-Educating staff to 
consistency ask for AD 
place AD in correct spot 
-Educate providers where 
AD can be found in 
EMR. 
Triggers for ACP Conversations 
-Annual visits 
-Repeated hospitalizations/ER visits  
-Change in function/health status (loss of 
ADLs, falls, change in living situation) 
-Disease progression (increase symptom 
burden/decreased QOL) 
 -New comorbid conditions 
-Serial increases in maintenance diuretic 
doses  
-ICD shocks 
-End stage heart failure (AHA stage D or 
NYHA stage IV) 
-any patient without an AD   
(Re) Assessment reveals 
Educate all clinicians regarding triggers for ACP conversations 
Obtain number of AD and number of billing codes for clinic through 
chart audit. Assess provider comfort, knowledge, attitudes toward ACP 
and clinic intake. 
Perform PDSA cycle, changing what does not 
work and reinforcing what does work for duration 
of QI project. 
Obtain number of AD and number of billing codes 
for clinic through chart audit. Assess provider 
comfort, knowledge, attitudes toward ACP and 
clinic intake. 
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Appendix C 
Matrix of Advance Care Planning Tools 
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s 
re
la
te
d
 t
o
 A
C
P
 
d
is
cu
ss
io
n
 a
n
d
 
d
o
cu
m
en
ta
ti
o
n
 
-O
n
ly
 s
ca
le
 n
o
t 
to
 s
h
o
w
 a
n
 
in
cr
ea
se
 w
as
 i
n
 
as
k
in
g
 
cl
in
ic
ia
n
s 
q
u
es
ti
o
n
s.
 
D
at
a 
A
n
al
y
si
s 
-B
as
el
in
e 
ch
ar
ac
te
ri
st
ic
s 
b
et
w
ee
n
 
g
ro
u
p
s 
co
m
p
ar
ed
 Χ
2
. 
 -M
ix
ed
 e
ff
ec
ts
 
li
n
ea
r 
m
o
d
el
 
co
m
p
ar
ed
 
su
b
sc
al
e 
sc
o
re
s 
o
f 
su
rv
ey
s.
 
 
-B
as
el
in
e 
an
d
 6
 
m
o
n
th
s 
fo
ll
o
w
 u
p
 
sc
o
re
s 
co
m
p
ar
ed
. 
O
u
tc
o
m
e 
M
ea
su
re
s 
-P
ri
m
ar
y
 
o
u
tc
o
m
es
: 
A
ss
es
s 
b
eh
av
io
r 
ch
an
g
e 
p
ro
ce
ss
es
 
an
d
 
ac
ti
o
n
s,
 
in
cl
u
d
in
g
 
d
is
cu
ss
io
n
s 
w
it
h
 f
am
il
y
 
m
em
b
er
s,
 
fr
ie
n
d
s,
 
an
d
 
su
rr
o
g
at
es
, 
an
d
 
d
o
cu
m
en
ta
ti
o
n
 
M
aj
o
r 
V
ar
ia
b
le
s 
-I
n
te
rv
en
ti
o
n
 
an
d
 c
o
n
tr
o
l 
g
ro
u
p
s 
re
ce
iv
ed
 A
C
P
 
en
g
ag
em
en
t 
su
rv
ey
. 
S
am
p
le
 
ch
ar
ac
te
ri
st
ic
s 
an
d
 s
et
ti
n
g
 
-V
et
er
an
s 
>
6
0
 
w
it
h
 ≥
2
 c
h
ro
n
ic
 
co
n
d
it
io
n
s,
 ≥
2
 
v
is
it
s 
w
it
h
 P
C
P
 
in
 p
as
t 
y
ea
r,
 a
n
d
 
≥
2
 E
R
, 
h
o
sp
it
al
, 
o
r 
o
u
tp
at
ie
n
t 
v
is
it
s 
in
 p
as
t 
y
ea
r.
 
 -N
=
4
1
4
 
 
-G
en
er
al
 
m
ed
ic
in
e 
o
u
tp
at
ie
n
t 
cl
in
ic
s 
at
 S
an
 
F
ra
n
ci
sc
o
 V
A
 
S
tu
d
y
 
D
es
ig
n
 
-S
in
g
le
 
b
li
n
d
, 
p
ar
al
le
l-
g
ro
u
p
, 
R
C
T
*
 
A
u
th
o
r,
 
Y
ea
r,
 t
o
o
l 
u
se
d
 
-L
u
m
 e
t 
al
.,
 
2
0
1
8
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L
ev
el
 o
f 
E
v
id
en
ce
 
-L
O
E
: 
IV
 
*
S
IC
G
=
S
er
io
u
s 
Il
ln
es
s 
C
ar
e 
G
u
id
e;
 
F
in
d
in
g
s 
-D
ec
ea
se
d
 
p
ar
ti
ci
p
an
ts
 a
t 
in
te
rv
en
ti
o
n
 
cl
in
ic
s 
h
ad
 m
o
re
 
se
ri
o
u
s 
il
ln
es
s 
co
n
v
er
sa
ti
o
n
s 
w
it
h
 c
li
n
ic
ia
n
s 
th
at
 w
er
e 
m
o
re
 
co
m
p
re
h
en
si
v
e 
an
d
 a
cc
es
si
b
le
 
as
 c
o
m
p
ar
ed
 t
o
 
co
n
tr
o
l 
cl
in
ic
s.
  
-N
o
 e
ff
ec
t 
se
en
 
o
n
 e
ar
li
er
 t
im
in
g
 
b
et
w
ee
n
 c
li
n
ic
s.
 
-N
o
 d
if
fe
re
n
ce
 
b
et
w
ee
n
 h
o
sp
ic
e 
u
sa
g
e 
b
et
w
ee
n
 
cl
in
ic
s.
 
-H
ig
h
 
sa
ti
sf
ac
ti
o
n
 
ra
te
s 
o
f 
cl
in
ic
ia
n
s 
co
m
p
le
ti
n
g
 
2
.5
-h
o
u
r 
tr
ai
n
in
g
. 
D
at
a 
A
n
al
y
si
s 
-D
es
cr
ip
ti
v
e 
st
at
is
ti
cs
 o
f 
d
ec
ea
se
d
, 
Χ
2
 
an
al
y
si
s 
to
 
co
m
p
ar
e 
g
ro
u
p
s,
 9
5
%
 
co
n
fi
d
en
ce
 
in
te
rv
al
. 
O
u
tc
o
m
e 
M
ea
su
re
s 
-P
ri
m
ar
y
 
o
u
tc
o
m
es
 
in
cl
u
d
ed
 
p
re
v
al
en
ce
, 
ti
m
in
g
, 
ac
ce
ss
ib
il
it
y
, 
an
d
 
co
m
p
re
h
en
si
v
en
es
s 
o
f 
se
ri
o
u
s 
il
ln
es
s 
co
n
v
er
sa
ti
o
n
s 
in
 
p
at
ie
n
ts
 w
h
o
 
d
ie
d
 d
u
ri
n
g
 
im
p
le
m
en
ta
ti
o
n
 
p
er
io
d
 u
si
n
g
 
re
tr
o
sp
ec
ti
v
e 
ch
ar
t 
re
v
ie
w
 
 
M
aj
o
r 
V
ar
ia
b
le
s 
-I
n
te
rv
en
ti
o
n
 
C
li
n
ic
s 
re
ce
iv
ed
 
a 
2
.5
-h
o
u
r 
tr
ai
n
in
g
 s
es
si
o
n
 
u
si
n
g
 t
h
e 
S
IC
G
*
 
an
d
 m
o
n
th
ly
 
co
ac
h
in
g
 c
al
l,
 
an
d
 a
n
 e
m
ai
l 
as
k
in
g
 c
li
n
ic
ia
n
s 
to
 a
sk
 t
h
e 
“S
u
rp
ri
se
 
Q
u
es
ti
o
n
” 
re
g
ar
d
in
g
 t
h
ei
r 
p
at
ie
n
t.
 
-C
o
n
tr
o
l 
C
li
n
ic
 
cl
in
ic
ia
n
s 
re
ce
iv
ed
 t
h
e 
“S
u
rp
ri
se
 
Q
u
es
ti
o
n
” 
S
am
p
le
 
ch
ar
ac
te
ri
st
ic
s 
an
d
 s
et
ti
n
g
 
-C
o
n
v
en
ie
n
ce
 
sa
m
p
le
 o
f 
6
 
cl
in
ic
s 
ch
o
se
n
 f
o
r 
lo
ca
ti
o
n
 a
n
d
 
h
ig
h
-r
is
k
 
p
o
p
u
la
ti
o
n
; 
8
 
cl
in
ic
s 
se
rv
ed
 a
s 
co
n
tr
o
l 
cl
in
ic
s 
 -N
=
1
4
 C
li
n
ic
s 
 
-C
li
n
ic
s 
w
er
e 
u
rb
an
 a
n
d
 
su
b
u
rb
an
, 
co
m
m
u
n
it
y
 a
n
d
 
h
o
sp
it
al
 b
as
ed
 
ac
ro
ss
 B
o
st
o
n
 
ar
ea
 
S
tu
d
y
 
D
es
ig
n
 
-P
ro
sp
ec
ti
v
e 
Q
u
as
i-
E
x
p
er
im
en
ta
l 
tr
ia
l 
A
u
th
o
r,
 
Y
ea
r,
 t
o
o
l 
u
se
d
 
-L
ak
in
 e
t 
al
.,
 
2
0
1
7
 
 
-T
o
o
l:
 
S
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u
s 
Il
ln
es
s 
C
ar
e 
P
ro
g
ra
m
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L
ev
el
 o
f 
E
v
id
en
ce
 
-L
O
E
: 
II
 
*
R
C
T
=
 R
an
d
o
m
iz
ed
 C
o
n
tr
o
ll
ed
 T
ri
al
; 
ⁱP
C
P
=
P
ri
m
ar
y
 C
ar
e 
P
ro
v
id
er
; 
E
M
R
◊
 =
E
le
ct
ro
n
ic
 M
ed
ic
al
 R
ec
o
rd
; 
 
F
in
d
in
g
s 
-I
n
te
rv
en
ti
o
n
 
g
ro
u
p
: 
In
cr
ea
se
d
 A
C
P
 
d
o
cu
m
en
ta
ti
o
n
 
b
y
 3
5
%
. 
 
 -C
o
n
tr
o
l 
g
ro
u
p
: 
In
cr
ea
se
d
 A
C
P
 
d
o
cu
m
en
ta
ti
o
n
 
b
y
 2
5
%
. 
 
-B
o
th
 
g
ro
u
p
s 
ra
te
d
 
th
e 
A
D
 e
as
y
 
to
 u
se
, 
w
er
e 
sa
ti
sf
ie
d
 
w
it
h
 t
h
e 
A
D
, 
w
o
u
ld
 
re
co
m
m
en
d
 
it
 t
o
 o
th
er
s,
 
an
d
 f
o
u
n
d
 i
t 
h
el
p
fu
l.
 
D
at
a 
A
n
al
y
si
s 
-B
as
el
in
e 
ch
ar
ac
te
ri
st
ic
s 
b
et
w
ee
n
 
g
ro
u
p
s 
co
m
p
ar
ed
 
u
si
n
g
 u
n
p
ai
re
d
 
t 
te
st
s,
 Χ
2
, 
F
is
h
er
 e
x
ac
t 
te
st
s.
 
 -I
n
te
n
ti
o
n
 t
o
 
tr
ea
t 
an
al
y
si
s.
  
 -P
 v
al
u
es
 2
 
ta
il
ed
 w
it
h
 
si
g
n
if
ic
an
ce
 o
f 
0
.0
5
. 
 
-M
ix
ed
 
ef
fe
ct
s 
lo
g
is
ti
c 
an
d
 
li
n
ea
r 
re
g
re
ss
io
n
. 
O
u
tc
o
m
e 
M
ea
su
re
s 
-P
ri
m
ar
y
 
o
u
tc
o
m
e 
m
ea
su
re
s:
 N
ew
 
A
C
P
 
d
o
cu
m
en
ta
ti
o
n
 
in
 E
M
R
◊
 9
 
m
o
n
th
s 
af
te
r 
st
u
d
y
 
en
ro
ll
m
en
t,
 
in
cl
u
d
in
g
 l
eg
al
 
fo
rm
s,
 
d
o
cu
m
en
te
d
 
d
is
cu
ss
io
n
s,
 o
r 
ch
an
g
es
 i
n
 c
o
d
e 
st
at
u
s.
 
-S
ec
o
n
d
ar
y
 
o
u
tc
o
m
e 
m
ea
su
re
s:
 
v
al
id
at
ed
 A
C
P
 
en
g
ag
em
en
t 
su
rv
ey
 
M
aj
o
r 
V
ar
ia
b
le
s 
-I
n
te
rv
en
ti
o
n
 
g
ro
u
p
: 
R
ec
ei
v
ed
 
P
R
E
P
A
R
E
 
w
eb
si
te
 a
n
d
 e
as
y
 
to
 r
ea
d
 A
D
 i
n
 
re
se
ar
ch
 o
ff
ic
e.
 
-C
o
n
tr
o
l 
g
ro
u
p
: 
re
ce
iv
ed
 e
as
y
 
to
 r
ea
d
 A
D
 i
n
 
re
se
ar
ch
 
o
ff
ic
e.
 
S
am
p
le
 
ch
ar
ac
te
ri
st
ic
s 
an
d
 s
et
ti
n
g
 
-V
et
er
an
s 
>
6
0
 
w
it
h
 ≥
2
 c
h
ro
n
ic
 
co
n
d
it
io
n
s,
 ≥
2
 
v
is
it
s 
w
it
h
 P
C
P
ⁱ 
in
 p
as
t 
y
ea
r,
 a
n
d
 
≥
2
 E
R
, 
h
o
sp
it
al
, 
o
r 
o
u
tp
at
ie
n
t 
v
is
it
s 
in
 p
as
t 
y
ea
r.
 
 -N
=
4
1
4
 
 
-G
en
er
al
 
m
ed
ic
in
e 
o
u
tp
at
ie
n
t 
cl
in
ic
s 
at
 S
an
 
F
ra
n
ci
sc
o
 V
A
 
S
tu
d
y
 
D
es
ig
n
 
-S
in
g
le
 
b
li
n
d
, 
p
ar
al
le
l-
g
ro
u
p
, 
R
C
T
*
 
A
u
th
o
r,
 
Y
ea
r,
 t
o
o
l 
u
se
d
 
-S
u
d
o
re
 e
t 
al
.,
 
2
0
1
7
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L
ev
el
 o
f 
E
v
id
en
ce
 
-L
O
E
: 
II
 
*
R
C
T
=
 R
an
d
o
m
iz
ed
 C
o
n
tr
o
ll
ed
 T
ri
al
; 
G
O
C
ⁱ=
 G
o
al
s 
o
f 
C
ar
e;
 Q
O
L
! 
=
 Q
u
al
it
y
 o
f 
L
if
e;
 C
P
R
◊
 =
C
ar
d
io
p
u
lm
o
n
ar
y
 R
es
u
sc
it
at
io
n
; 
F
in
d
in
g
s 
-I
n
te
rv
en
ti
o
n
 a
rm
: 
2
2
%
 p
re
fe
rr
ed
 l
if
e 
p
ro
lo
n
g
in
g
 c
ar
e,
 5
1
%
 
co
m
fo
rt
 c
ar
e,
 2
5
%
 
li
m
it
ed
 m
ed
ic
al
 c
ar
e,
 
an
d
 2
%
 w
er
e 
u
n
ce
rt
ai
n
. 
C
o
n
tr
o
l 
A
rm
: 
4
1
%
 p
re
fe
rr
ed
 
li
fe
 p
ro
lo
n
g
in
g
 c
ar
e,
 
2
2
%
 l
im
it
ed
 m
ed
ic
al
 
ca
re
, 
3
0
%
 c
o
m
fo
rt
 
ca
re
 a
n
d
 7
%
 
u
n
ce
rt
ai
n
 (
P
<
0
.0
0
1
).
 
-I
n
te
rv
en
ti
o
n
 a
rm
 
6
8
%
/7
8
%
 w
o
u
ld
 
fo
rg
o
 C
P
R
/I
n
tu
b
at
io
n
 
v
s 
3
5
%
 /
4
8
%
 i
n
 
co
n
tr
o
l 
ar
m
 (
P
<
0
.0
0
1
 
an
d
 P
<
0
.0
0
1
).
 
-W
it
h
 b
as
el
in
e 
sc
o
re
s 
si
m
il
ar
, 
in
te
rv
en
ti
o
n
 a
rm
 
p
ar
ti
ci
p
an
ts
 h
ad
 
h
ig
h
er
 m
ea
n
 
k
n
o
w
le
d
g
e 
sc
o
re
s 
re
g
ar
d
in
g
 A
C
P
 
o
p
ti
o
n
s 
(4
.1
±
1
.4
 
v
s.
 3
.0
±
1
.5
; 
P
<
0
.0
0
1
).
 
D
at
a 
A
n
al
y
si
s 
-C
o
m
p
ar
ed
 
G
O
C
 a
n
d
 
C
P
R
/i
n
tu
b
at
io
n
 d
es
ir
es
 
b
et
w
ee
n
 
g
ro
u
p
s 
u
si
n
g
 
Χ
2
. 
-C
o
m
p
ar
ed
 
m
ea
n
 
k
n
o
w
le
d
g
e 
sc
o
re
s 
o
f 
g
ro
u
p
s 
u
si
n
g
 2
 
sa
m
p
le
 t
 t
es
t.
 
U
se
d
 Κ
 
st
at
is
ti
cs
 f
o
r 
ag
re
em
en
t 
in
 e
ac
h
 
st
u
d
y
 a
rm
. 
O
u
tc
o
m
e 
M
ea
su
re
s 
-P
ri
m
ar
y
 
o
u
tc
o
m
e:
 
P
at
ie
n
ts
 i
n
 
in
te
rv
en
ti
o
n
 
g
ro
u
p
 w
o
u
ld
 
p
re
fe
r 
ca
re
 
fo
cu
se
d
 o
n
 
Q
O
L
!  
an
d
 
co
m
fo
rt
 
co
m
p
ar
ed
 t
o
 
co
n
tr
o
l 
g
ro
u
p
. 
 
-S
ec
o
n
d
ar
y
 
o
u
tc
o
m
es
: 
In
te
rv
en
ti
o
n
 
g
ro
u
p
 w
o
u
ld
 
d
es
ir
e 
C
P
R
◊
/v
en
ti
la
t
o
r 
le
ss
, 
b
e 
m
o
re
 
k
n
o
w
le
d
g
ea
b
l
e 
ab
o
u
t 
A
C
P
, 
an
d
 h
av
e 
m
o
re
 
A
C
P
 
co
n
v
er
sa
ti
o
n
s 
w
it
h
 
cl
in
ic
ia
n
s.
 
M
aj
o
r 
V
ar
ia
b
le
s 
-I
n
te
rv
en
ti
o
n
 
g
ro
u
p
: 
R
ec
ei
v
ed
 
d
es
cr
ip
ti
o
n
 o
f 
3
 
G
O
C
ⁱ r
ea
d
 b
y
 
re
se
ar
ch
 
as
si
st
an
t,
 v
ie
w
ed
 
6
-m
in
u
te
 G
O
C
 
v
id
eo
, 
re
ce
iv
ed
 
an
 A
C
P
 
ch
ec
k
li
st
. 
 
-C
o
n
tr
o
l 
g
ro
u
p
: 
R
ec
ei
v
ed
 
d
es
cr
ip
ti
o
n
 o
f 
3
 G
O
C
 r
ea
d
 
b
y
 r
es
ea
rc
h
 
as
si
st
an
t 
S
am
p
le
 
ch
ar
ac
te
ri
st
ic
s 
an
d
 s
et
ti
n
g
 
-≥
6
4
-y
ea
r-
o
ld
, 
E
n
g
li
sh
 s
p
ea
k
in
g
 
p
at
ie
n
ts
 w
it
h
 
es
ta
b
li
sh
ed
 
d
ia
g
n
o
si
s 
o
f 
ad
v
an
ce
d
 h
ea
rt
 
fa
il
u
re
. 
 -N
=
2
4
6
 
 
-M
u
lt
is
it
e 
in
p
at
ie
n
t 
te
ac
h
in
g
 
h
o
sp
it
al
s 
ar
o
u
n
d
 U
.S
. 
S
tu
d
y
 
D
es
ig
n
 
-R
C
T
*
 
A
u
th
o
r,
 
Y
ea
r,
 t
o
o
l 
u
se
d
 
-E
l-
 J
aw
ah
ri
 
et
 a
l.
, 
2
0
1
6
 
   -T
o
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L
ev
el
 o
f 
E
v
id
en
ce
 
-L
O
E
:I
V
 
*
P
C
P
=
P
ri
m
ar
y
 C
ar
e 
P
ro
v
id
er
; 
 
F
in
d
in
g
s 
-U
n
k
n
o
w
n
 i
f 
an
y
 
p
ar
ti
ci
p
at
ed
 i
n
 
co
n
v
er
sa
ti
o
n
s 
w
it
h
 P
C
P
; 
re
se
ar
ch
er
s 
u
n
ab
le
 
to
 c
o
n
ta
ct
 P
C
P
’s
. 
-9
2
%
 s
ta
te
d
 v
id
eo
 
w
as
 h
el
p
fu
l 
-8
6
%
 s
ta
te
d
 t
h
ey
 
d
id
 n
o
t 
d
is
li
k
e 
an
y
th
in
g
 i
n
 v
id
eo
. 
-A
ft
er
 6
 
m
o
n
th
s,
 1
2
/3
7
 
p
at
ie
n
ts
 
st
at
ed
/h
ad
 
ev
id
en
ce
 i
n
 
ch
ar
t 
o
f 
co
m
p
le
ti
n
g
 
A
C
P
 
d
o
cu
m
en
ta
ti
o
n
. 
D
at
a 
A
n
al
y
si
s 
M
cN
em
ar
’s
 
te
st
 u
se
d
 t
o
 
an
al
y
ze
 
b
ef
o
re
 a
n
d
 
af
te
r 
in
te
rv
en
ti
o
n
 
d
at
a.
 
O
u
tc
o
m
e 
M
ea
su
re
s 
-F
ea
si
b
il
it
y
 o
f 
u
si
n
g
 a
n
 
ed
u
ca
ti
o
n
al
 
v
id
eo
 t
o
 
im
p
ro
v
e 
co
m
p
le
ti
o
n
 
ra
te
s 
o
f 
A
D
 o
r 
P
O
L
S
T
 f
o
rm
s.
 
M
aj
o
r 
V
ar
ia
b
le
s 
-I
n
te
rv
en
ti
o
n
 
w
as
 a
n
 
ed
u
ca
ti
o
n
al
 
v
id
eo
 a
b
o
u
t 
A
C
P
 t
o
 
st
im
u
la
te
 
co
n
v
er
sa
ti
o
n
s 
w
it
h
 
o
u
tp
at
ie
n
t 
cl
in
ic
ia
n
s 
S
am
p
le
 
ch
ar
ac
te
ri
st
ic
s 
an
d
 s
et
ti
n
g
 
-≥
5
0
 E
n
g
li
sh
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Appendix D 
Modified AGREE II Tool 
DOMAIN 1. SCOPE AND PURPOSE   
1. The overall objective(s) of the protocol is (are) specifically described. 
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
 
2. The health question(s) covered by the protocol is (are) specifically described.  
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
 
3. The population (patients, public, etc.) to whom the protocol is meant to apply is specifically 
described. 
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
  
 DOMAIN 2. STAKEHOLDER INVOLVEMENT  
5. The views and preferences of the target population (patients, public, etc.) have been sought.   
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
 
6. The target users of the protocol are clearly defined 
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
 
DOMAIN 3. RIGOUR OF DEVELOPMENT  
7. Systematic methods were used to search for evidence.   
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
 
8. The criteria for selecting the evidence are clearly described.   
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
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9. The strengths and limitations of the body of evidence are clearly described. 
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
 
DOMAIN 4. CLARITY OF PRESENTATION   
15. The recommendations are specific and unambiguous.  
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
 
16. The different options for management of the condition or health issue are clearly presented.   
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
 
DOMAIN 5. APPLICABILITY  
18. The protocol describes facilitators and barriers to its application.   
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
 
19. The protocol provides advice and/or tools on how the recommendations can be put into 
practice.   
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
 
20. The potential resource implications of applying the recommendations have been considered.   
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
 
       (AGREE Next Steps Consortium, 2017) 
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Appendix E 
Demographic Information 
 
1) Title (circle one):    Physician             Physician’s Assistant                    Nurse Practitioner 
2) Years of experience as a cardiology provider: ______________ 
3) Age: __________ 
4) Gender: _______________ 
5) Location of Clinic (rural vs. metropolitan): ___________________ 
Protocol Review Questions 
1) After reviewing the protocol and using the modified AGREE II tool, how feasible do you 
think it is to implement this protocol in your clinic? 
 
 
 
 
2) How do you think this protocol could be made stronger/ more complete? 
 
 
 
 
3) What are the barriers you see to implementing a protocol like this? 
 
 
 
4) Do you think this protocol, or something like it, would be useful to you or your clinic? 
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Appendix F 
Advanced Care Planning Provider Questions 
Advance care planning (ACP) is the process of discussing a patient’s medical wishes and 
goals in the event they cannot make decisions for themselves. This discussion goes beyond, “If 
you were unresponsive and needed CPR, defibrillation, a breathing tube, or other life-sustaining 
measures, would you want it?” ACP is a discussion about goals of care, which ensures that 
patients understand their illness and disease trajectory; furthermore, it explains and offers 
interventions that best align patients’ goals. This is a process and not a one-time discussion and 
should be re-evaluated periodically. Knowing this, please answer the following questions. 
 
1) What is your way of knowing when an ACP conversation needs to take place? 
 
 
 
 
 
2) How comfortable are you facilitating an ACP discussion? (please mark where you fall) 
Not Comfortable---------Somewhat comfortable---------Comfortable---------Very Comfortable 
 
3) Do you have a format you follow for ACP discussions?             Yes                  No 
If so, what format do you use and where did you obtain it from? 
 
4) Do you feel that ACP discussions are your responsibility?         Yes                  No 
5) Do you know where you can get resources for patients or yourself if needed?  
Yes                No 
6) Where can you find a patient’s AD in the chart? 
7) Do you know how to bill for an ACP conversation? 
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Appendix G 
Clinic Flow Sheet to Identify Patients for ACP 
Does the patient have an AD?                     Yes              No 
 
If no, has the patient recently experienced any of the following? (Circle all that apply) 
 Recent hospitalizations/ER visits due to heart failure 
  
 Change in function/health status (loss of ADLs, falls, change in living situation) 
  
 Signs of disease progression (increase symptom burden/decreased QOL) 
  
 New comorbid conditions 
  
 Increase in maintenance diuretic doses  
  
 ICD shock 
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Appendix H 
Example of ACP Documentation Template 
Advance Care Planning/Goals of Care Conversation 
Persons present for conversation: (Put names and relationship to patient) 
Medical Condition/ Comorbidities: (Could be useful if it self populates) 
Details of conversation (include direct quotes from patient or surrogate): Patient’s values, 
concerns, fears, preferences, and specifics of life preserving interventions, future 
hospitalizations, and hospice. 
Outcome of Conversation: (Desire for future hospitalizations, code status if hospitalized) 
Documents completed as a result of conversation: (AD, Living Will, DPOAHC, TPOPP, 
POLST/MOLST) 
Other documents present that outline patient/surrogate wishes: 
Time: “I have spent a total of ___ minutes in face to face discussion of patient condition, 
prognosis, treatment goals, and advance care planning with the patient and/or surrogate decision 
makers.” 
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Appendix I 
Example of ACP Documentation 
Advance Care Planning/Goals of Care Conversation 
Persons present for conversation: John (patient), Samantha (Wife), and children Ryan and 
Kelsey. 
Medical Conditions/Comorbidities: Coronary Heart Disease, Aortic stenosis with TAVR, 
GERD. 
Details of conversation (include direct quotes from patient or surrogate): John and his family 
watched the PREPARE for your care online tool. John has decided to make his son, Ryan, his 
DPOAHC.  
John stated “I would prefer a life that I could actually live, instead of living in the hospital, or on 
a machine. But if there is something that could be done to fix whatever is wrong with me, I 
would be open to that. Like when there was something wrong with my heart valve. They 
replaced it and my symptoms got a lot better.” 
John wants a full code status in the hospital. 
John stated, “If it is my time to die, then I am alright with that. I need the you and the other 
doctors to tell me what is realistic and what is not.” 
Outcome of Conversation: Full code status if hospitalized.  
Documents completed as a result of conversation: DPOAHC- Son Ryan 
Other documents present that outline patient/surrogate wishes: None 
Time: “I have spent a total of ___ minutes in face to face discussion of patient condition, 
prognosis, treatment goals, and advance care planning with the patient and/or surrogate decision 
makers.” 
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  71 
 
      (Bernacki & Block, 2014) 
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Appendix K
 
         (Ariadne Labs, 2017) 
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Appendix L 
Stakeholder Concept Map 
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Appendix M 
Power Versus Interest Grid 
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